美国私人保险覆盖人群中 40 多岁女性乳腺癌筛查的应用和费用。
Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance.
机构信息
Department of Health Management and Health Economics, Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway.
Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
出版信息
JAMA Intern Med. 2020 May 1;180(5):799-801. doi: 10.1001/jamainternmed.2020.0262.
Abstract
This study uses Blue Cross Blue Shield Axis data to examine the total annual cost of breast cancer screening for women aged 40 through 49 years in the United States.
摘要
本研究使用 Blue Cross Blue Shield Axis 数据，考察了美国 40 至 49 岁女性乳腺癌筛查的总年度成本。
相似文献
1
Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance.美国私人保险覆盖人群中 40 多岁女性乳腺癌筛查的应用和费用。
JAMA Intern Med. 2020 May 1;180(5):799-801. doi: 10.1001/jamainternmed.2020.0262.
2
Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model.基于人群的乳腺癌筛查项目中转换为数字化乳腺摄影的预算影响分析：离散事件模拟模型
PLoS One. 2014 May 15;9(5):e97459. doi: 10.1371/journal.pone.0097459. eCollection 2014.
3
The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.数字乳腺断层合成在人群乳腺癌筛查计划中的成本效益。
Eur Radiol. 2020 Oct;30(10):5437-5445. doi: 10.1007/s00330-020-06812-x. Epub 2020 May 7.
4
To what extent is women's economic situation associated with cancer screening uptake when nationwide screening exists? A study of breast and cervical cancer screening in France in 2010.在全国范围内开展筛查的情况下，女性的经济状况与癌症筛查的接受程度有多大关联？2010年法国乳腺癌和宫颈癌筛查研究。
Cancer Causes Control. 2014 Aug;25(8):977-83. doi: 10.1007/s10552-014-0397-z. Epub 2014 May 20.
5
A quest for quality and economic effectiveness throughout the continuum of breast care.在整个乳腺护理连续过程中追求质量和经济效益。
Breast. 2010 Aug;19(4):251-2. doi: 10.1016/j.breast.2010.03.020. Epub 2010 Apr 13.
6
The patient burden of screening mammography recall.筛查性乳房 X 光摄影召回的患者负担。
J Womens Health (Larchmt). 2014 Sep;23 Suppl 1:S11-9. doi: 10.1089/jwh.2014.1511.
7
Performance Goals for an Adjunct Diagnostic Test to Reduce Unnecessary Biopsies After Screening Mammography: Analysis of Costs, Benefits, and Consequences.辅助诊断测试在乳腺钼靶筛查后减少不必要活检的性能目标：成本、效益及后果分析
J Am Coll Radiol. 2016 Nov;13(11S):R81-R88. doi: 10.1016/j.jacr.2016.09.032.
8
Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.参保高免赔额保险后对乳腺癌的诊断和治疗
J Clin Oncol. 2018 Apr 10;36(11):1121-1127. doi: 10.1200/JCO.2017.75.2501. Epub 2018 Feb 28.
9
Utilization and Cost of Mammography Screening Among Commercially Insured Women 50 to 64 Years of Age in the United States, 2012-2016.美国 2012-2016 年商业保险女性 50-64 岁人群的乳腺 X 线筛查利用情况和成本。
J Womens Health (Larchmt). 2020 Mar;29(3):327-337. doi: 10.1089/jwh.2018.7543. Epub 2019 Oct 15.
10
Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.国家乳腺癌和宫颈癌早期检测计划中患者导航用于乳腺癌筛查的成本效益分析。
Cancer Causes Control. 2019 Sep;30(9):923-929. doi: 10.1007/s10552-019-01200-3. Epub 2019 Jul 11.
引用本文的文献
1
Machine learning can reliably predict malignancy of breast lesions based on clinical and ultrasonographic features.机器学习可以根据临床和超声特征可靠地预测乳腺病变的恶性程度。
Breast Cancer Res Treat. 2025 Jun;211(3):581-593. doi: 10.1007/s10549-024-07429-0. Epub 2024 Jul 13.
2
Identifying and Reducing Barriers to Breast Imaging.识别并减少乳腺成像的障碍
Curr Breast Cancer Rep. 2023;15(2):114-118. doi: 10.1007/s12609-023-00480-8. Epub 2023 Apr 5.
3
Behaviour within a Clinical Trial and Implications for Mammography Guidelines.临床试验中的行为及其对乳腺钼靶检查指南的影响。
Rev Econ Stud. 2023 Jan;90(1):432-462. doi: 10.1093/restud/rdac022. Epub 2022 May 9.
4
Predicting factors for breast cancer screening in Middle Eastern women based on health belief model: a systematic review.基于健康信念模型的中东女性乳腺癌筛查预测因素：系统评价。
J Egypt Natl Canc Inst. 2022 Dec 5;34(1):50. doi: 10.1186/s43046-022-00150-3.
5
Yap-Hippo Signaling Activates Mitochondrial Protection and Sustains Breast Cancer Viability under Hypoxic Stress.Yap-Hippo信号通路激活线粒体保护作用并维持缺氧应激下乳腺癌的生存能力。
J Oncol. 2021 Sep 13;2021:5212721. doi: 10.1155/2021/5212721. eCollection 2021.
6
Mammograms and Mortality: How Has the Evidence Evolved?乳房X光检查与死亡率：证据是如何演变的？
J Econ Perspect. 2021 Spring;35(2):119-140. doi: 10.1257/jep.35.2.119.
7
Understanding Regional Variation in the Cost of Breast Cancer Screening Among Privately Insured Women in the United States.了解美国私人保险女性乳腺癌筛查成本的地区差异。
Med Care. 2021 May 1;59(5):437-443. doi: 10.1097/MLR.0000000000001506.
本文引用的文献
1
Long-Term Outcomes and Cost-Effectiveness of Breast Cancer Screening With Digital Breast Tomosynthesis in the United States.在美国，数字乳腺断层合成筛查乳腺癌的长期结果和成本效益。
J Natl Cancer Inst. 2020 Jun 1;112(6):582-589. doi: 10.1093/jnci/djz184.
2
Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age.使用协作模拟建模来开发一个基于网络的工具，以支持关于乳腺癌筛查起始年龄的政策层面决策。
MDM Policy Pract. 2017 Jul;2(2). doi: 10.1177/2381468317717982. Epub 2017 Jul 8.
3
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.美国不同乳腺癌筛查策略相关获益与危害的协同建模
Ann Intern Med. 2016 Feb 16;164(4):215-25. doi: 10.7326/M15-1536. Epub 2016 Jan 12.
4
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.美国乳腺 X 光筛查的总费用：当前实践与倡导指南的比较。
Ann Intern Med. 2014 Feb 4;160(3):145. doi: 10.7326/M13-1217.
5
Distinguishing screening from diagnostic mammograms using Medicare claims data.利用医疗保险索赔数据区分筛查性和诊断性乳房 X 光检查。
Med Care. 2014 Jul;52(7):e44-51. doi: 10.1097/MLR.0b013e318269e0f5.
Zotero 插件